{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"}],"units":"Participants"}],"description":"Peripheral blood chimerism studies were performed by quantitative real time polymerase chain reaction (qPCR) evaluation of differential short tandem repeat DNA sequences","groups":[{"description":"Conditioning with Alemtuzumab, busulfan and fludarabine followed by allogeneic hematopoietic cell transplant.","id":"OG000","title":"Single Arm - Transplant Pre-conditioning Per Study Protocol"}],"paramType":"NUMBER","populationDescription":"Participants evaluable for engraftment 6 weeks post-transplant; 1 patient died of transplant-related hemorrhage prior to 6 weeks and was not evaluated for this outcome","reportingStatus":"POSTED","timeFrame":"6 weeks post-transplant","title":"Number of Participants Achieving Durable Engraftment (Presence of Donor Cells) at 6 Weeks Post Transplantation","type":"PRIMARY","unitOfMeasure":"participants"}